Xylen shares have underperformed over the last six months, up 1% compared to a gain of 13% for the S&P 500, offering a buying opportunity, Argus tells investors in a research note. Argus says Xylem’s (XYL) business is “fine,” and that the company has indicated confidence in its outlook with a recent 11% dividend increase. The firm, which is maintaining a Buy rating and $145 price target is looking for margin expansion from new growth opportunities and notes that Xylem is using partnerships and other acquisitions to expand its offerings, particularly in the utility and industrial end markets.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XYL: